Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Annals of the Rheumatic Diseases|April 17, 2026
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritisVictoria Konzett, Faidra Laskou, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|June 2, 2026
Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task ForceVictoria Konzett, Faidra Laskou, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|April 16, 2025
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024Kevin L Winthrop, Joan Bathon, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension studyDaniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases|August 7, 2021
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritisKulveer Mankia, Heidi J Siddle, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|April 24, 2026
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025Kevin L Winthrop, Andreas Kerschbaumer, John D Isaacs, et al.
Annals of the Rheumatic Diseases|September 15, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controlsFelix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|February 24, 2023
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumaticaChristian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|November 7, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statementPeter Nash, Andreas Kerschbaumer, Thomas Dörner, et al.
Pageof 6